SciELO - Scientific Electronic Library Online

 
vol.4 issue1Importance of hyperphosphatemia in chronic kidney disease, how to avoid it and treat it by nutritional measuresHow useful in the daily practice of nephrologists are the new antidiabetics with cadiovascular protection? author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Nefrología

On-line version ISSN 2500-5006

Abstract

BOSCH-PANADERO, Enrique et al. Bisphenol (A) uremic toxin to take into account in the Renal disease in Hemodialysis. Rev. colom. nefrol. [online]. 2017, vol.4, n.1, pp.57-68. ISSN 2500-5006.  https://doi.org/10.22265/acnef.41.256.

Introduction:

Most uremic toxins are by-products of protein metabolism by action of intestinal flora. The metabolism of aromatic amino acids originates phenolic type residues. The most studied is p-cresol that is associated with renal function and vascular damage. Bisphenol A (BPA) is an exogenous molecule with characteristics similar to these aromatic uremic toxins. BPA is an estrogenic endocrine disruptor, found in tin cans, plastic bottles, epoxy resins and in some dialyzers. This molecule accumulates in patients who have impaired renal function. Observational studies have shown that exposure of BPA is linked to renal and cardiovascular injury, among many others in humans, and in animal studies a causal link has been described. Kidneys with normal renal function rapidly excrete BPA, but insufficient excretion in patients with CKD results in accumulation of BPA in the body.

Keywords : Uremic toxin; Bisphenol A; chronic kidney disease; endocrine disruptor; hemodialysis.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )